Skip Navigation


Carcinogenesis Advance Access originally published online on April 21, 2007
Carcinogenesis 2007 28(10):2172-2183; doi:10.1093/carcin/bgm096
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/10/2172    most recent
bgm096v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Suryo Rahmanto, Y.
Right arrow Articles by Richardson, D.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suryo Rahmanto, Y.
Right arrow Articles by Richardson, D.R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo

Y. Suryo Rahmanto, L.L. Dunn and D.R. Richardson*

Iron Metabolism and Chelation Program, Department of Pathology, Blackburn Building D06, University of Sydney, Sydney, New South Wales, 2006 Australia

* To whom correspondence should be addressed. Tel: +61 2 9036 6548; Fax: +61 2 9036 6549; Email: d.richardson{at}pathology.usyd.edu.au

Melanoma tumor antigen p97 or melanotransferrin (MTf) is an iron (Fe)-binding protein with high homology to serum transferrin. MTf is expressed at very low levels in normal tissues and in high amounts in melanoma cells although its function remains elusive. To understand the function of MTf, we utilized whole-genome microarray analysis to examine the gene expression profile of five models after modulating MTf expression. These models included two new stably transfected MTf hyper-expression models (SK-N-MC neuroepithelioma and LMTK fibroblasts) and one cell type (SK-Mel-28 melanoma) where MTf was down-regulated by post-transcriptional gene silencing. These findings were compared with alterations in gene expression identified using the MTf–/– mice. In addition, the changes identified from the microarray data were also assessed in a new model of MTf down-regulation in SK-Mel-2 melanoma cells. In the cell line models, MTf hyper-expression led to increased proliferation, whereas MTf down-regulation resulted in decreased proliferation. Across all five models of MTf down- and up-regulation, we identified three genes modulated by MTf. These included ATP-binding cassette subfamily B member 5, whose change in expression mirrored MTf down- or up-regulation. In addition, thiamine triphosphatase and transcription factor 4 were inversely expressed relative to MTf levels across all five models. The products of these three genes are involved in membrane transport, thiamine phosphorylation and proliferation/survival, respectively. This study identifies novel molecular targets directly or indirectly regulated by MTf and the potential pathways involved in its function, including modulation of proliferation.

Abbreviations: Abcb5, ATP-binding cassette subfamily B member 5; Apod, apolipoprotein D; Mef2a, myocyte enhancer factor 2a; MTf, melanotransferrin; PTGS, post-transcriptional gene silencing; RT-PCR, reverse transcription–polymerase chain reaction; Tcf4, transcription factor 4; Tf, transferrin; TfR1, transferrin receptor 1; Thtpa, thiamine triphosphatase

Received January 23, 2007; revised March 17, 2007; accepted April 11, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.